Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Trials reveal efficacy of REGN-727 in treating hypercholesterolemia

April 3, 2012

Roche divulges novel HDL cholesterol-increasing agents

April 2, 2012

Immunotherapy potently reduces LDL cholesterol in phase I trials

April 2, 2012

Novel acetyl-CoA carboxylase 2 inhibitors presented

April 2, 2012

Pfizer and Astellas amend Lipitor licensing agreement

March 30, 2012

Zeria files for approval of oral phosphate hypophosphatemia drug in Japan

March 30, 2012

Antisense therapy shows promise in phase I study

March 30, 2012

Anacetrapib improves dyslipidemia in Japanese trial

March 30, 2012

Lexicon Pharmaceuticals provides first description of early development of LX-4211

March 30, 2012

DSMB recommends continuation of Menerba study

March 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...